164 related articles for article (PubMed ID: 38102712)
1. Recurring EPHB1 mutations in human cancers alter receptor signalling and compartmentalisation of colorectal cancer cells.
Kundu S; Nunes L; Adler J; Mathot L; Stoimenov I; Sjöblom T
Cell Commun Signal; 2023 Dec; 21(1):354. PubMed ID: 38102712
[TBL] [Abstract][Full Text] [Related]
2. Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer.
Mathot L; Kundu S; Ljungström V; Svedlund J; Moens L; Adlerteg T; Falk-Sörqvist E; Rendo V; Bellomo C; Mayrhofer M; Cortina C; Sundström M; Micke P; Botling J; Isaksson A; Moustakas A; Batlle E; Birgisson H; Glimelius B; Nilsson M; Sjöblom T
Cancer Res; 2017 Apr; 77(7):1730-1740. PubMed ID: 28108514
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer-associated mutations impair EphB1 kinase function.
Kim Y; Ahmed S; Miller WT
J Biol Chem; 2023 Sep; 299(9):105115. PubMed ID: 37527777
[TBL] [Abstract][Full Text] [Related]
4. Ligand-dependent EphB1 signaling suppresses glioma invasion and correlates with patient survival.
Teng L; Nakada M; Furuyama N; Sabit H; Furuta T; Hayashi Y; Takino T; Dong Y; Sato H; Sai Y; Miyamoto K; Berens ME; Zhao SG; Hamada J
Neuro Oncol; 2013 Dec; 15(12):1710-20. PubMed ID: 24121831
[TBL] [Abstract][Full Text] [Related]
5. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1.
Freywald A; Sharfe N; Roifman CM
J Biol Chem; 2002 Feb; 277(6):3823-8. PubMed ID: 11713248
[TBL] [Abstract][Full Text] [Related]
6. EphB1 is underexpressed in poorly differentiated colorectal cancers.
Sheng Z; Wang J; Dong Y; Ma H; Zhou H; Sugimura H; Lu G; Zhou X
Pathobiology; 2008; 75(5):274-80. PubMed ID: 18931529
[TBL] [Abstract][Full Text] [Related]
7. Paradoxes of the EphB1 receptor in malignant brain tumors.
Wei W; Wang H; Ji S
Cancer Cell Int; 2017; 17():21. PubMed ID: 28194092
[TBL] [Abstract][Full Text] [Related]
8. In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins.
Chakraborty S; Baruah R; Mishra N; Varma AK
Genomics Inform; 2023 Sep; 21(3):e30. PubMed ID: 37813626
[TBL] [Abstract][Full Text] [Related]
9. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
[TBL] [Abstract][Full Text] [Related]
10. EphB1-mediated cell migration requires the phosphorylation of paxillin at Tyr-31/Tyr-118.
Vindis C; Teli T; Cerretti DP; Turner CE; Huynh-Do U
J Biol Chem; 2004 Jul; 279(27):27965-70. PubMed ID: 15107421
[TBL] [Abstract][Full Text] [Related]
11. Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathway.
Fasen K; Cerretti DP; Huynh-Do U
Traffic; 2008 Feb; 9(2):251-66. PubMed ID: 18034775
[TBL] [Abstract][Full Text] [Related]
12. Nck recruitment to Eph receptor, EphB1/ELK, couples ligand activation to c-Jun kinase.
Stein E; Huynh-Do U; Lane AA; Cerretti DP; Daniel TO
J Biol Chem; 1998 Jan; 273(3):1303-8. PubMed ID: 9430661
[TBL] [Abstract][Full Text] [Related]
13. Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms.
Lisabeth EM; Fernandez C; Pasquale EB
Biochemistry; 2012 Feb; 51(7):1464-75. PubMed ID: 22242939
[TBL] [Abstract][Full Text] [Related]
14. Mutations in the RAS and PI3K pathways are associated with metastatic location in colorectal cancers.
Lan YT; Jen-Kou L; Lin CH; Yang SH; Lin CC; Wang HS; Chen WS; Lin TC; Jiang JK; Chang SC
J Surg Oncol; 2015 Jun; 111(7):905-10. PubMed ID: 25920435
[TBL] [Abstract][Full Text] [Related]
15. Protein Tyrosine Phosphatase Non-Receptor 11 (
Richards CE; Elamin YY; Carr A; Gately K; Rafee S; Cremona M; Hanrahan E; Smyth R; Ryan D; Morgan RK; Kennedy S; Hudson L; Fay J; O'Byrne K; Hennessy BT; Toomey S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445722
[No Abstract] [Full Text] [Related]
16. Loss of expression of EphB1 protein in gastric carcinoma associated with invasion and metastasis.
Wang JD; Dong YC; Sheng Z; Ma HH; Li GL; Wang XL; Lu GM; Sugimura H; Jin J; Zhou XJ
Oncology; 2007; 73(3-4):238-45. PubMed ID: 18424888
[TBL] [Abstract][Full Text] [Related]
17. EphB1 associates with Grb7 and regulates cell migration.
Han DC; Shen TL; Miao H; Wang B; Guan JL
J Biol Chem; 2002 Nov; 277(47):45655-61. PubMed ID: 12223469
[TBL] [Abstract][Full Text] [Related]
18. PI3K expression and PIK3CA mutations are related to colorectal cancer metastases.
Zhu YF; Yu BH; Li DL; Ke HL; Guo XZ; Xiao XY
World J Gastroenterol; 2012 Jul; 18(28):3745-51. PubMed ID: 22851869
[TBL] [Abstract][Full Text] [Related]
19. The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function.
Makarov R; Steiner B; Gucev Z; Tasic V; Wieacker P; Wieland I
BMC Med Genet; 2010 Jun; 11():98. PubMed ID: 20565770
[TBL] [Abstract][Full Text] [Related]
20. Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome.
Niethamer TK; Teng T; Franco M; Du YX; Percival CJ; Bush JO
PLoS Genet; 2020 Feb; 16(2):e1008300. PubMed ID: 32092051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
